Phenotypic and Molecular Detection of Antiseptic Resistance Genes among Clinical Staphylococcus aureus Isolates during COVID-19 Pandemic

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Badawi H.; Reda A.; El Said M.; El-Far A.; Magdy R.; El-Shenawy A.; Yousry N.

Journal: Journal of Pure and Applied Microbiology

Publisher: Journal of Pure and Applied Microbiology

Publication Date: 1 November 2022

Volume / Issue: Volume 16 / Issue 4

Pages: 2619–2630

ISSN: 9737510

DOI: 10.22207/JPAM.16.4.29

Scopus: View on Scopus

Document Type: Article

Access: All Open Access; Gold Open Access


Authors and Affiliations

Badawi H., Department of Microbiology & Infection Prevention & Control Unit, Theodor Bilharz Research Institute (TBRI), Giza, 12411, Egypt; Reda A., Department of Microbiology & Immunology, Faculty of Medicine, Cairo University, Egypt; El Said M., Department of Microbiology & Infection Prevention & Control Unit, Theodor Bilharz Research Institute (TBRI), Giza, 12411, Egypt, Department of Microbiology, Medicine Program, Batterjee Medical College, Jeddah, 21442, Saudi Arabia; El-Far A., Department of Microbiology, Theodor Bilharz Research Institute, (TBRI), Egypt; Magdy R., Department of Microbiology & Infection Prevention & Control Unit, Theodor Bilharz Research Institute (TBRI), Giza, 12411, Egypt; El-Shenawy A., Department of Microbiology, Theodor Bilharz Research Institute, (TBRI), Egypt; Yousry N., Department of Microbiology, Theodor Bilharz Research Institute, (TBRI), Egypt


Abstract

The coronavirus disease (COVID-19) pandemic has expanded the use of chlorhexidine digluconate, a biocide frequently used in hospitals, to inhibit the spread of infection. Genes responsible for resistance against the quaternary ammonium compound qac in Staphylococcus aureus isolates have been shown to confer tolerance to a number of biocidal chemicals, including chlorhexidine. The aim of this study was to determine the occurrence of antiseptic resistance genes (qacA/B and qacC) in clinical isolates of methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). The study also aimed to investigate the association between the presence of the mecA, qacA/B, and qacC genes in MRSA isolates and the susceptibility of the isolates to chlorhexidine to evaluate its future use in the Theodor Bilharz Research Institute (TBRI) hospital, following the Centers for Disease Control and Prevention recommendations for patients with MRSA. S. aureus isolates (n = 100) were collected from inpatients and outpatients at TBRI. A minimal inhibitory concentration of chlorhexidine was also detected. Polymerase chain reaction was used to detect the mecA, qacA/B, and qacC genes. The results revealed that 84% of S. aureus isolates were MRSA. MRSA (61.9%) and MSSA (68.8%) isolates were susceptible to chlorhexidine. The qacA/B gene was more dominant, being detected in 34%, while qacC was detected in only 5% of S. aureus isolates. All S. aureus isolates with reduced susceptibility to chlorhexidine harbored either the qacA/B or qacC genes. The clinical use of chlorhexidine may continue to increase, emphasizing the significance of continuous caution underlining the emergence of new clones with reduced susceptibility and avoiding antiseptic misuse. © The Author(s) 2022.


Keywords

Antiseptic Resistance; Chlorhexidine; MRSA; MSSA; qacA/B; qacC Genes; Staphylococcus aureus; catalase; cefoxitin; ciprofloxacin; clindamycin; coagulase; cotrimoxazole; erythromycin; gentamicin; glycerol; linezolid; mannitol; membrane protein; meticillin; moxifloxacin; oxacillin; penicillin binding protein 2a; qaca protein; qacb protein; qacc protein; quaternary ammonium derivative; unclassified drug; vancomycin; adult; Article; bacterium isolate; clinical evaluation; controlled study; coronavirus disease 2019; disease association; disease control; genetic resistance; genetic susceptibility; hand washing; hospital patient; human; human tissue; infection prevention; methicillin resistant Staphylococcus aureus; methicillin susceptible Staphylococcus aureus; microbiological examination; minimum inhibitory concentration; outpatient care; pandemic; phenotypic variation; polymerase chain reaction


Citation Information

Scopus Citations: 2


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer